NCT00957606

Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer

Osteoporosis Among Men Treated With Androgen Deprivation for Prostate Cancer: Symptoms, Risc Factors, and Prevention

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 100 (estimated)
• Sponsor: Odense University Hospital · Academic / Other
• Sex: Male
• Age: —
• Healthy volunteers: Not accepted

Summary

The purpose of this study is * to determine the rate of osteoporosis among patients with advanced prostate cancer. * to propose an algorithm for early detection of patients with advanced prostate cancer who are at risk of developing osteoporosis.

Detailed description

Patients with advanced prostate cancer are included at the initiating of androgen deprivation therapy. The patients are followed for 2 years after inclusion with blood sampling, DXA-scan, questionnaire, bone scintigraphy.

Conditions

• Prostate Cancer
• Androgen Deprivation Therapy
• Osteoporosis

Interventions

Type	Name	Description
PROCEDURE	blood sampling, DXA-scan, bone scintigraphy	Blood sampling 5 times DXA-scan 5 times Bone scintigraphy 3 times

Timeline

• Start date: 2009-08-01
• Primary completion: 2013-03-01
• Completion: 2013-09-01
• First posted: 2009-08-12
• Last updated: 2011-04-13

Locations

2 sites across 1 country: Denmark